Dr. Violaine Harris's and Dr. Saud Sadiq's research on fetuin-A as a CSF biomarker for active MS has been featured on the cover of this month’s issue of the Multiple Sclerosis Journal! This important biomarker discovery is based on spinal fluid measurement of Fetuin-A levels obtained over the course of several years of clinical and pathological studies of MS patients as well as experimental models of the disease.  Our findings are likely to change the process for making treatment decisions...

Dr. Brenda Banwell spoke at Grand Rounds this week on the subject of pediatric multiple sclerosis. Dr. Banwell is the chief of pediatric neurology at Children’s Hospital of Philadelphia as well as the director of the pediatric multiple sclerosis clinic at the Hospital for Sick Children in Toronto. Pediatric MS is far less common than adult MS and behaves somewhat differently in several ways. Studying patients as early as possible in the disease course as well as their differences to adult...

Dr. Jonathan Vapnek provided Grand Rounds this week. Dr. Vapnek is a urologist with a focus on the urologic complications of neurologic diseases. He practices on the upper east side of Manhattan and at Mt. Sinai Hospital. During the lecture, he reviewed the approach and management of urologic symptoms in neurological conditions, and provided an interesting perspective on novel treatments and procedures.

To the IMSMP Family and Supporters of the Tisch MS Research Center of New York,  It gives me great pride and joy to announce that the FDA has approved our Phase I clinical trial for the use of bone marrow-derived neural stem cells in the treatment of multiple sclerosis. This exciting development is the culmination of a decade long effort by the dedicated team of scientists at the Tisch MS Research Center of New York at a cost of several million dollars. In treating patients with MS,...